MedPath

STATIN-PRE trial

Phase 3
Not yet recruiting
Conditions
intrauterine growth restriction
preeclampsia
Registration Number
2024-519853-12-00
Lead Sponsor
Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau
Brief Summary

To assess that daily 40 mgr of oral administration of pravastatin in pregnant individuals with PE and/or IUGR between 24.0 and 29.6 weeks of gestation will prolong duration of pregnancy compared to conventional management.

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised, recruitment pending
Sex
Female
Target Recruitment
154
Inclusion Criteria

Singleton fetus.

Between 24+0 to 29+6 weeks of gestation at the inclusion

Early-onset severe PE: women with a diagnosis of severe-preterm PE who are candidates for expectant management and have no clinical indication for immediate delivery, based on the clinical assessments of the attending doctors.

And/or IUGR: Diagnosis of early onset IUGR according to the SMFM classification with umbilical artery Doppler with absent/reversed diastolic flow; or estimated fetal weight <10th percentile plus pulsatility index (PI) of umbilical artery Doppler >95th percentil.

Able to give informed consent.

Exclusion Criteria

Established maternal or fetal compromise that necessitated immediate delivery

Abnormal karyotype, structural abnormalities, or congenital infections.

Treatment with pravastatin or other statins prior to inclusion.

Active liver disease, including persistent and unexplained elevations of serum transaminases (3 times above the upper limit).

Study & Design

Study Type
Not specified
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Days of prolongation of pregnancy between inclusion and delivery; continuous (days).

Days of prolongation of pregnancy between inclusion and delivery; continuous (days).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (4)

Hospital De La Santa Creu I Sant Pau

🇪🇸

Barcelona, Spain

Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca

🇪🇸

Barcelona, Spain

Universitat Autonoma De Barcelona

🇪🇸

Bellaterra, Spain

Hospital Clinic De Barcelona

🇪🇸

Barcelona, Spain

Hospital De La Santa Creu I Sant Pau
🇪🇸Barcelona, Spain
ELISA LLURBA
Site contact
935537048
ELlurba@santpau.cat

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.